Join
Live feed
·
INSIDERFilingvia Quantisnow
Arrowhead Pharmaceuticals Inc. logo

Chief Discovery/Trans Medicine Hamilton James C was granted 100,000 shares and sold $648,824 worth of shares (32,729 units at $19.82), increasing direct ownership by 33% to 272,122 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ARWR· Arrowhead Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARWR (Arrowhead Pharmaceuticals Inc.) and more on Quantisnow.